Reversible thrombotic aortic valve restenosis after valve-in-valve transcatheter aortic valve replacement
Reversible thrombotic aortic valve restenosis after valve-in-valve transcatheter aortic valve replacement
复制标题
DOI：
10.1002/ccd.26522
复制
发表时间：
2018-01-01
影响因子：
2.3
通讯作者：
Don, Creighton W.
中科院分区：
文献类型：
--
作者：
Goleski, Patrick J.;Reisman, Mark;Don, Creighton W.
经导管主动脉瓣置换术（TAVR）后血栓性主动脉瓣再狭窄尚未得到广泛报告，TAVR瓣膜血栓形成率未知。我们报告了3例使用球囊扩张式经导管心脏瓣膜行TAVR术后瓣中瓣（VIV）再狭窄的病例，可能是由于抗凝治疗改善了瓣膜血栓形成。(c)2016 Wiley Periodicals，Inc.
Thrombotic aortic valve restenosis following transcatheter aortic valve replacement (TAVR) has not been extensively reported and the rates of TAVR valve thrombosis are not known. We present three cases of valve-in-valve (VIV) restenosis following TAVR with the balloon expandable transcatheter heart valves, presumably due to valve thrombosis that improved with anticoagulation. (c) 2016 Wiley Periodicals, Inc.